Study of the Structure and Biological Activity of the Amino-Terminus of the α-Toxin from Clostridium welchii Type A
- PMID: 31286181
- DOI: 10.1007/s00284-019-01733-5
Study of the Structure and Biological Activity of the Amino-Terminus of the α-Toxin from Clostridium welchii Type A
Abstract
To explore the biological activity of Clostridium welchii α-toxin (CPA), the Asp56 residue of CPA was mutated to glycine (CPA D56G) by site-directed mutagenesis, and the 250 amino acid amino-terminal phospholipase C (PLC)-containing domain of CPA (PLC1-250) was isolated. The secondary and three-dimensional (3D) structures of CPA D56G and PLC1-250 were predicted, and the results showed that the secondary structures of CPA D56G and PLC1-250 were composed of α-helices and random coils. The 3D structures of CPA D56G and PLC1-250 were similar to the 3D structures of CPA. The circular dichroism (CD) spectrum of CPA D56G differed from the CD spectrum of CPA, but the CD spectrum of PLC1-250 was similar to the CD spectrum of CPA. Biological activity assays showed that CPA D56G lost the PLC activity of CPA and that mice immunized with CPA D56G were protected against a challenge with 1 MLD C. welchii type A strain C57-1. In addition, PLC1-250 contained the PLC activity of CPA. This study laid a solid foundation for future studies on the relationship between the molecular structure and biological function of CPA and its molecular mechanism. Our study also provided CPA D56G as a candidate strain for engineering a CPA subunit vaccine for C. welchii type A.
Similar articles
-
Molecular structure and function of the carboxy-terminus of the alpha-toxin from Clostridium perfringens type A.J Anim Physiol Anim Nutr (Berl). 2020 Mar;104(2):725-734. doi: 10.1111/jpn.13274. Epub 2019 Dec 23. J Anim Physiol Anim Nutr (Berl). 2020. PMID: 31872485
-
Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.BMC Biotechnol. 2020 Jan 28;20(1):7. doi: 10.1186/s12896-019-0597-4. BMC Biotechnol. 2020. PMID: 31992276 Free PMC article.
-
Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.Infect Immun. 2001 Nov;69(11):7194-6. doi: 10.1128/IAI.69.11.7194-7196.2001. Infect Immun. 2001. PMID: 11598102 Free PMC article.
-
Vaccines against Clostridium perfringens alpha-toxin.Curr Pharm Biotechnol. 2013;14(10):913-7. doi: 10.2174/1389201014666131226124348. Curr Pharm Biotechnol. 2013. PMID: 24372250 Review.
-
Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding.Int J Med Microbiol. 2000 Oct;290(4-5):357-61. doi: 10.1016/s1438-4221(00)80040-5. Int J Med Microbiol. 2000. PMID: 11111911 Review.
Cited by
-
Review of advances in molecular structure and biological function of alpha toxin of Clostridium perfringens.Can J Vet Res. 2024 Oct;88(4):138-144. Can J Vet Res. 2024. PMID: 39355682 Free PMC article. Review.
-
Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase.FEBS Open Bio. 2021 Dec;11(12):3262-3275. doi: 10.1002/2211-5463.13320. Epub 2021 Nov 8. FEBS Open Bio. 2021. PMID: 34709730 Free PMC article. Review.
References
-
- Lacey JA, Allnutt TR, Vezina B, Van TTH, Stent T, Han X, Rood JI, Wade B, Keyburn AL, Seemann T, Chen H, Haring V, Johanesen PA, Lyras D, Moore RJ (2018) Whole genome analysis reveals the diversity and evolutionary relationships between necrotic enteritis-causing strains of Clostridium perfringens. BMC Genom 19(1):379 - DOI
-
- Mwangi S, Timmons J, Fitz-Coy S, Parveen S (2018) Characterization of Clostridium perfringens recovered from broiler chicken affected by necrotic enteritis. Poult Sci 98:128–135 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous